ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals Inc

ORIC

Market Cap$338.8M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ORIC Pharmaceuticals IncORIC Pharmaceuticals Inc-2.6--49%--
$0.85

Current Fair Value

83.7% downside

Overvalued by 83.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$338.80 Million
Enterprise Value$282.57 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.83
Beta1.37
Outstanding Shares70,652,013

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-2.64
PEG-7.39
Price to Sales-
Price to Book Ratio1.74
Enterprise Value to Revenue183.73
Enterprise Value to EBIT-2.09
Enterprise Value to Net Income-3
Total Debt to Enterprise0.01
Debt to Equity0.01

Revenue Sources

No data

Insider Trades

ESG Score

No data

About ORIC Pharmaceuticals Inc

CEO: Jacob Chacko